Search - tctmd.com

Displaying 41 - 60 of 245

Sort: Relevancy | Date

Presentation TCT 2022

Prevention of Radial Artery Occlusion With Rivaroxaban After Transradial Coronary Procedures: The RIVARAD Multicentric Randomized Trial

Presenter: Rania Hammami

September 19, 2022

Presentation TCT 2022

Randomized, Double-Blind Trial of Routine Early Treatment With PCSK-9 inhibitor in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

Presenter: Shamir Mehta

September 19, 2022

Presentation TCT 2022

Discussion - What does this Field Need Next?

Presenter: Felix Mahfoud

September 19, 2022

Presentation TCT 2022

Who Should be Treated with uRDN?

Presenter: Naomi Fisher

September 19, 2022

Presentation TCT 2022

Discussion - Key Takeaways from the RADIANCE Clinical Program

Presenter: Felix Mahfoud

September 19, 2022

Presentation TCT 2022

Late-Breaking Evidence from RADIANCE II

Presenter: Michel Azizi

September 19, 2022

Presentation TCT 2022

Introduction and Objectives

Presenter: Felix Mahfoud

September 19, 2022

Presentation TCT 2022

FAME 3 Substudies: Clinical Outcomes Related to Anatomic vs Functional Significance and Prognostic Value of Post-PCI FFR II

Presenter: Zsolt Piroth

September 19, 2022

Presentation TCT 2022

FAME 3 Substudies: Clinical Outcomes Related to Anatomic vs Functional Significance and Prognostic Value of Post-PCI FFR

Presenter: Yuhei Kobayashi

September 19, 2022

Presentation TCT 2022

A Randomised Controlled Trial Assessing the Value of Computed Tomography Cardiac Angiography (CTCA) in Improving Patient Satisfaction and Reducing Contrast Load, Procedural Duration, and Complications in Patients Who Had Previous Bypass Operation (CABG)…

Presenter: Daniel Jones

September 19, 2022

Presentation TCT 2022

FLASH 800 and clinical implications

Presenter: Catalin Toma

September 19, 2022

Presentation TCT 2022

Why intervene in submassive patients

Presenter: Wissam Jaber

September 19, 2022

Presentation TCT 2022

Survival After PCI or CABG for Left Main Coronary Disease: A Report From the Swedish Coronary Angiography and Angioplasty Registry

Presenter: Elmir Omerovic

September 19, 2022

Presentation TCT 2022

FlowTriever in high-risk patients

Presenter: Sanjum Sethi

September 19, 2022

Presentation TCT 2022

Introduction to the PE/VTE landscape and critical unmet needs

Presenter: Shon Chakrabarti

September 19, 2022

Presentation TCT 2022

Everolimus-Eluting Stents or Bypass Surgery for Mutivessel Coronary Artery Disease: 10-Year Outcomes of Multicenter Randomized Controlled BEST Trial

Presenter: Jung-Min Ahn

September 19, 2022

Presentation TCT 2022

State-of-the-Art Lecture: Future Device Therapies in PE

Presenter: Robert Lookstein

September 19, 2022

Presentation TCT 2022

Myocardial Intramural Remodeling by Endovenous TeTHer (MIRTH)

Presenter: Chris Bruce

September 19, 2022

Presentation TCT 2022

Intermediate-Risk PE Case (NewYork-Presbyterian/Columbia University Irving Medical Center): Case Conclusion

Presenter: Sanjum Sethi

September 19, 2022

Presentation TCT 2022

What Do the Clinical Trials Tell Us to Do in Intermediate-Risk PE?

Presenter: Eric Secemsky

September 19, 2022

Advertisement

Prevention of Radial Artery Occlusion With Rivaroxaban After Transradial Coronary Procedures: The RIVARAD Multicentric Randomized Trial

Randomized, Double-Blind Trial of Routine Early Treatment With PCSK-9 inhibitor in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

Discussion - What does this Field Need Next?

Who Should be Treated with uRDN?

Discussion - Key Takeaways from the RADIANCE Clinical Program

Late-Breaking Evidence from RADIANCE II

Introduction and Objectives

FAME 3 Substudies: Clinical Outcomes Related to Anatomic vs Functional Significance and Prognostic Value of Post-PCI FFR II

FAME 3 Substudies: Clinical Outcomes Related to Anatomic vs Functional Significance and Prognostic Value of Post-PCI FFR

A Randomised Controlled Trial Assessing the Value of Computed Tomography Cardiac Angiography (CTCA) in Improving Patient Satisfaction and Reducing Contrast Load, Procedural Duration, and Complications in Patients Who Had Previous Bypass Operation (CABG)…

FLASH 800 and clinical implications

Why intervene in submassive patients

Survival After PCI or CABG for Left Main Coronary Disease: A Report From the Swedish Coronary Angiography and Angioplasty Registry

FlowTriever in high-risk patients

Introduction to the PE/VTE landscape and critical unmet needs

Everolimus-Eluting Stents or Bypass Surgery for Mutivessel Coronary Artery Disease: 10-Year Outcomes of Multicenter Randomized Controlled BEST Trial

State-of-the-Art Lecture: Future Device Therapies in PE

Myocardial Intramural Remodeling by Endovenous TeTHer (MIRTH)

Intermediate-Risk PE Case (NewYork-Presbyterian/Columbia University Irving Medical Center): Case Conclusion

What Do the Clinical Trials Tell Us to Do in Intermediate-Risk PE?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content